基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the detailed record of transactions filed by Brudnick Richard. Insider active across 2 companies, notably Scholar Rock Holding Corp. Cumulatively, 5 filings have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €143k. Activity tracked since 27 June 2024. The latest transaction was filed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Brudnick Richard is a declarant linked to Scholar Rock Holding Corp and Prime Medicine, Inc., where he is Director and Chief Business Officer. Across the 5 filings on record, the 5 most recent filings run from 2024-07-01 to 2026-06-08, with EUR 21076 of buys and EUR 121745 of sells, and the most common transaction nature is Attribution.